{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T11:52:10Z","timestamp":1753876330415,"version":"3.41.2"},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"vor","delay-in-days":11,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Calcium channel blockers are the first-line treatment option, followed by long-acting nitrates or nicorandil as second-line medications for patient with coronary artery spasm (CAS). However, there are cases where symptoms cannot be controlled by a combination of these drugs. The drug choice after first- and second-line treatment options is varied and challenging.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Case summary<\/jats:title>\n                  <jats:p>A 70-year-old woman presented to our hospital with complaints of angina at rest. The patient was diagnosed with CAS based on a positive acetylcholine provocation test result. Nitrates were intolerable due to headaches. The combination of calcium channel blocker and nicorandil was not effective in mitigating her symptoms. Four potential symptom relief drugs\u2014trimetazidine, shigyakusan, keishibukuryogan, and denopamine\u2014were prescribed. Each drug was administered for one week, and symptom improvement was assessed one month later. Two drugs (shigyakusan and keishibukuryogan) were effective in relieving her symptoms, but neither was satisfactory on its own. Therefore, these two drugs were combined and added on top of the calcium channel blocker and nicorandil. Her symptoms were well controlled thereafter.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>The drug challenge test, which involves prescribing various types of drugs for short durations to evaluate their effects, may be an effective option for quickly controlling symptoms in patients with refractory CAS who exhibit frequent symptoms.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ehjcr\/ytaf134","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T03:40:12Z","timestamp":1744083612000},"source":"Crossref","is-referenced-by-count":0,"title":["Drug challenge test for early symptom control in patients with coronary artery spasm: a case report"],"prefix":"10.1093","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8060-5274","authenticated-orcid":false,"given":"Yoshiaki","family":"Kawase","sequence":"first","affiliation":[{"name":"Department of Cardiology, Gifu Heart Center , 4-14-4 Yabutaminami, Gifu City, Gifu 500-8384 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kento","family":"Kikuchi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Gifu Heart Center , 4-14-4 Yabutaminami, Gifu City, Gifu 500-8384 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Mizukami","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Gifu Heart Center , 4-14-4 Yabutaminami, Gifu City, Gifu 500-8384 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Matsuo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Gifu Heart Center , 4-14-4 Yabutaminami, Gifu City, Gifu 500-8384 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,4,8]]},"reference":[{"key":"2025043005414197300_ytaf134-B1","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0002-9149(82)80008-8","article-title":"Diltiazem for long-term therapy of coronary arterial spasm","volume":"49","author":"Schroeder","year":"1982","journal-title":"Am J Cardiol"},{"key":"2025043005414197300_ytaf134-B2","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0735-1097(87)80397-2","article-title":"Comparison of diltiazem and nifedipine alone and in combination in patients with coronary artery spasm","volume":"9","author":"Prida","year":"1987","journal-title":"J Am Coll Cardiol"},{"key":"2025043005414197300_ytaf134-B3","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.15420\/ecr.2022.47","article-title":"Management of coronary artery spasm","volume":"18","author":"Lanza","year":"2023","journal-title":"Eur Cardiol"},{"key":"2025043005414197300_ytaf134-B4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jjcc.2023.06.009","article-title":"JCS\/CVIT\/JCC 2023 guideline focused update on diagnosis and treatment of vasospastic angina (coronary spastic angina) and coronary microvascular dysfunction","volume":"82","author":"Hokimoto","year":"2023","journal-title":"J Cardiol"},{"key":"2025043005414197300_ytaf134-B5","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","article-title":"2024 ESC guidelines for the management of chronic coronary syndromes","volume":"45","author":"Vrints","year":"2024","journal-title":"Eur Heart J"},{"key":"2025043005414197300_ytaf134-B6","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.jacc.2015.02.060","article-title":"Increased numbers of coronary events in winter and spring due to coronary artery spasm: effect of age, sex, smoking, and inflammation","volume":"65","author":"Hung","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2025043005414197300_ytaf134-B7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ijcard.2005.03.012","article-title":"Effectiveness of low dose denopamine, a beta1-adrenoceptor agonist, in a patient with vasospastic angina refractory to intensive medical treatment","volume":"108","author":"Nakajima","year":"2006","journal-title":"Int J Cardiol"},{"key":"2025043005414197300_ytaf134-B8","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/0002-9149(88)91238-6","article-title":"Refractory variant angina relieved by guanethidine and clonidine","volume":"62","author":"Frenneaux","year":"1988","journal-title":"Am J Cardiol"},{"key":"2025043005414197300_ytaf134-B9","doi-asserted-by":"crossref","first-page":"e176","DOI":"10.1016\/j.jccase.2012.07.010","article-title":"Refractory variant angina with a seasonal trend treated with sarpogrelate hydrochloride","volume":"6","author":"Liu","year":"2012","journal-title":"J Cardiol Cases"},{"key":"2025043005414197300_ytaf134-B10","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0167-5273(03)00022-6","article-title":"Beneficial effects of betaxolol, a selective antagonist of beta-1 adrenoceptors, on exercise-induced myocardial ischemia in patients with coronary vasospasm","volume":"91","author":"Suzuki","year":"2003","journal-title":"Int J Cardiol"},{"key":"2025043005414197300_ytaf134-B11","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/clc.23239","article-title":"Effect of sarpogrelate and high-dose statin on the reduction of coronary spasm in vasospastic angina: a two by two factorial, pilot randomized study","volume":"42","author":"Kim","year":"2019","journal-title":"Clin Cardiol"},{"key":"2025043005414197300_ytaf134-B12","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/S0002-9149(98)00640-7","article-title":"Effects of doxazosin on exercise-induced angina pectoris, ST-segment depression, and insulin sensitivity in patients with syndrome X","volume":"82","author":"Botker","year":"1998","journal-title":"Am J Cardiol"},{"key":"2025043005414197300_ytaf134-B13","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000362380","article-title":"Peripheral arterial function and coronary microvascular function in patients with variant angina","volume":"129","author":"Parrinello","year":"2014","journal-title":"Cardiology"}],"container-title":["European Heart Journal - Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/9\/4\/ytaf134\/62886125\/ytaf134.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/9\/4\/ytaf134\/62886125\/ytaf134.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T09:41:52Z","timestamp":1746006112000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcr\/article\/doi\/10.1093\/ehjcr\/ytaf134\/8107919"}},"subtitle":[],"editor":[{"given":"Andrew Peter","family":"Vanezis","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Muhammad Usman","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Terentes-Printzios","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Maria Isabel Gonzalez","family":"Del Hoyo","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,3,28]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,3,28]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcr\/ytaf134","relation":{},"ISSN":["2514-2119"],"issn-type":[{"type":"electronic","value":"2514-2119"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2025,3,28]]},"article-number":"ytaf134"}}